TOM Weight Loss Review
Best for: Texas or Utah patients wanting direct ABOM-certified physician access at competitive flat-rate pricing
Solo-physician DTC telemedicine clinic in Texas + Utah operated by Dr. Tran Le, MD (ABOM-board-certified obesity medicine, ABPM-certified addiction + occupational medicine, NPI 1194212258). Operating entity Texas Obesity Medicine, PLLC d/b/a TOM Weight Loss. Compounded semaglutide $199/mo flat-rate (up to 2.4 mg/week); compounded tirzepatide $249/mo flat-rate (up to 15 mg/week). Every patient sees Dr. Le directly. LegitScript badge displayed.
Medium confidence · Last verified 2026-05-25 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
TOM Weight Loss is one of the most affordable GLP-1 options on the market.
Score Breakdown
Drugs Offered
TOM Weight Loss prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Up to 2.4 mg/week (Basic, all doses) | compounded | $199 |
| Up to 15 mg/week (Premium, all doses) | compounded | $249 |
✓ Pros
- •ABOM board-certified physician (Dr. Tran Le, NPI 1194212258, verified ACTIVE)
- •Solo-physician model — every patient sees Dr. Le directly
- •Flat-rate pricing — no dose escalation surcharge
- •LegitScript badge displayed
- •No FDA Warning Letters
- •Trustpilot 4.6/5 (~31 reviews)
✗ Cons
- •Limited geographic footprint — Texas and Utah only
- •No named compounding pharmacy partner disclosed
- •Compounded medications are not FDA-approved
- •Cash-pay only, no insurance
Ready to start with TOM Weight Loss?
Starting at $199/month. See current pricing and start your free consultation.
Sources & methodology
Our TOM Weight Loss review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to TOM Weight Loss
Belle Health
Best for: Cost-sensitive patients comfortable with the Feb-2026 FDA warning, wanting flat-rate pricing and dietitian-included support
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with TOM Weight Loss?
Starting at $199/month. See current pricing and start your free consultation.